Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

Comments for:

Dietary sugars: a fat difference
Susanna M. Hofmann, Matthias H. Tschöp
Susanna M. Hofmann, Matthias H. Tschöp
Published April 20, 2009
Citation Information: J Clin Invest. 2009;119(5):1089-1092. https://doi.org/10.1172/JCI39332.
View: Text | PDF
Commentary

Dietary sugars: a fat difference

  • Text
  • PDF
Abstract

Coronary heart disease is a major cause of morbidity and mortality in Western societies. The metabolic syndrome, characterized by obesity, insulin resistance, elevated blood pressure, elevated triglycerides, and low levels of high-density lipoprotein cholesterol, confers substantial risk of coronary heart disease. Current pathogenetic models suggest that postprandial hyperlipidemia is one specific metabolic abnormality that is typically associated with increased morbidity. In this issue of the JCI, Stanhope and colleagues demonstrate that consumption of fructose-sweetened but not glucose-sweetened beverages for 10 weeks increases de novo lipid synthesis, promotes dyslipidemia, impairs insulin sensitivity, and increases visceral adiposity in overweight or obese adults (see the related article beginning on page 1322).

Authors

Susanna M. Hofmann, Matthias H. Tschöp

×

Restraint urged in extrapolation of unphysiologic fructose experimentation to predictions of real-world outcomes

Submitter: John White | white.tech.res@gmail.com

White Technical Research

Published March 10, 2010

In their commentary accompanying the recent mechanistic paper from Peter Havel’s group (1), Hoffman & Tschöp (2) do not show the same restraint Havel does in extrapolating his admittedly unphysiologic results to typical human diets.

Their focus on added sugars disregards the importance of looking at all caloric sources. Energy intake over the past 35 years from added sugars, flour/cereal and fats increased 50, 190 and 300 cal/d, respectively (3). We are not just taking in more fructose sweetener; we are eating more of everything.

The authors confuse two commercial products. Pure (crystalline) fructose is a specialty ingredient used for specific functional reasons comprising <1% of the sweetener market (4). High fructose corn syrup (HFCS) is nearly equal parts fructose and glucose; it is now generally agreed to be metabolically equivalent to sucrose (5-8).

Hoffman & Tschöp fail to put Havel’s work into proper perspective—there are no reliable data that fructose poses a specific health risk at typical intake levels (9.1% of energy) (9). The fructose diet used by Havel at 25% of energy is a poor model for the typical human diet on two counts: it tests pure sugars in isolation, whereas fructose and glucose are nearly always taken together in fruits/vegetable/nuts or added sugars (sucrose, HFCS, fruit juice concentrates, honey); and it uses levels 2.5-fold higher than mean consumption levels and 50% greater than even the highest consumers of fructose (95th percentile <18% of energy).

It is precisely because of the lack of perspective offered by Hoffman & Tschöp and others that the public is now convinced fructose poses a health risk, when in reality none has been demonstrated in humans at typical intake levels.

Conflict of interest statement: The author is a consultant to the food and beverage industry in the area of nutritive sweeteners. His clients include research institutes, food industry councils, trade organizations and individual companies.

References

  1. Stanhope, K.L., Schwarz, J.M., Keim, N.L., Griffen, S.C., Bremer, A.A., Graham, J.L., Hatcher, B., Cox, C.L., Dyachenko, A., Zhang, W., et al. 2009. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119:1322-1334.
  2. Hofmann, S.M., and Tschöp, M.H. 2009. Dietary sugars: a fat difference. J Clin Invest 119:1089-1092.
  3. Buzby, J., and Wells, H.F. 2007. Loss-Adjusted Food Availability Data: Calories. USDA-Economic Research Service.
  4. Hanover, L.M., and White, J.S. 1993. Manufacturing, composition, and applications of fructose. Am J Clin Nutr 58:724S-732S.
  5. Fulgoni, V., 3rd. 2008. High-fructose corn syrup: everything you wanted to know, but were afraid to ask. Am J Clin Nutr 88:1715S.
  6. American Medical Association. 17 June 2008. AMA finds high fructose syrup unlikely to be more harmful to health than other caloric sweeteners. Chicago: American Medical Association.
  7. American Dietetic Association. 2009. High fructose corn syrup and weight status. In Hot Topics.
  8. Jones, J.M. 2009. Dietary sweeteners containing fructose: overview of a workshop on the state of the science. J Nutr 139:1210S-1213S.
  9. Marriott, B.P., Cole, N., and Lee, E. 2009. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 139:1228S-1235S.

Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts